Literature DB >> 25436420

The green tea polyphenol (-)-epigallocatechin gallate prevents the aggregation of tau protein into toxic oligomers at substoichiometric ratios.

Heike J Wobst1, Apurwa Sharma2, Marc I Diamond2, Erich E Wanker3, Jan Bieschke4.   

Abstract

The accumulation of amyloid-beta (Aβ) and tau aggregates is a pathological hallmark of Alzheimer's disease. Both polypeptides form fibrillar deposits, but several lines of evidence indicate that Aβ and tau form toxic oligomeric aggregation intermediates. Depleting such structures could thus be a powerful therapeutic strategy. We generated a fragment of tau (His-K18ΔK280) that forms stable, toxic, oligomeric tau aggregates in vitro. We show that (-)-epigallocatechin gallate (EGCG), a green tea polyphenol that was previously found to reduce Aβ aggregation, inhibits the aggregation of tau K18ΔK280 into toxic oligomers at ten- to hundred-fold substoichiometric concentrations, thereby rescuing toxicity in neuronal model cells.
Copyright © 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  (−)-Epigallocatechin gallate; Aggregation inhibitors; Alzheimer‘s disease; Polyphenol; Tau oligomers; Tau protein

Mesh:

Substances:

Year:  2014        PMID: 25436420      PMCID: PMC4565179          DOI: 10.1016/j.febslet.2014.11.026

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  40 in total

Review 1.  Tau gene mutations in frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17). Their relevance for understanding the neurogenerative process.

Authors:  M Goedert; B Ghetti; M G Spillantini
Journal:  Ann N Y Acad Sci       Date:  2000       Impact factor: 5.691

2.  Inhibition of protein aggregation in vitro and in vivo by a natural osmoprotectant.

Authors:  Zoya Ignatova; Lila M Gierasch
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-09       Impact factor: 11.205

3.  Enhancement of cancer chemosensitization potential of cisplatin by tea polyphenols poly(lactide-co-glycolide) nanoparticles.

Authors:  Madhulika Singh; Priyanka Bhatnagar; Amit K Srivastava; Pradeep Kumar; Yogeshwer Shukla; Kailash C Gupta
Journal:  J Biomed Nanotechnol       Date:  2011-02       Impact factor: 4.099

4.  Fibers of tau fragments, but not full length tau, exhibit a cross beta-structure: implications for the formation of paired helical filaments.

Authors:  A M Giannetti; G Lindwall; M F Chau; M J Radeke; S C Feinstein; L A Kohlstaedt
Journal:  Protein Sci       Date:  2000-12       Impact factor: 6.725

5.  Anthraquinones inhibit tau aggregation and dissolve Alzheimer's paired helical filaments in vitro and in cells.

Authors:  Marcus Pickhardt; Zuzana Gazova; Martin von Bergen; Inna Khlistunova; Yipeng Wang; Antje Hascher; Eva-Maria Mandelkow; Jacek Biernat; Eckhard Mandelkow
Journal:  J Biol Chem       Date:  2004-11-02       Impact factor: 5.157

6.  Chemical chaperones interfere with the formation of scrapie prion protein.

Authors:  J Tatzelt; S B Prusiner; W J Welch
Journal:  EMBO J       Date:  1996-12-02       Impact factor: 11.598

7.  Identification of oligomers at early stages of tau aggregation in Alzheimer's disease.

Authors:  Cristian A Lasagna-Reeves; Diana L Castillo-Carranza; Urmi Sengupta; Jose Sarmiento; Juan Troncoso; George R Jackson; Rakez Kayed
Journal:  FASEB J       Date:  2012-01-17       Impact factor: 5.191

8.  Green tea extracts interfere with the stress-protective activity of PrP and the formation of PrP.

Authors:  Angelika S Rambold; Margit Miesbauer; Diana Olschewski; Ralf Seidel; Constanze Riemer; Lindsay Smale; Lisa Brumm; Michal Levy; Ehud Gazit; Dieter Oesterhelt; Michael Baier; Christian F W Becker; Martin Engelhard; Konstanze F Winklhofer; Jörg Tatzelt
Journal:  J Neurochem       Date:  2008-08-07       Impact factor: 5.372

Review 9.  Natural compounds may open new routes to treatment of amyloid diseases.

Authors:  Jan Bieschke
Journal:  Neurotherapeutics       Date:  2013-07       Impact factor: 7.620

10.  Amyloid beta protein gene: cDNA, mRNA distribution, and genetic linkage near the Alzheimer locus.

Authors:  R E Tanzi; J F Gusella; P C Watkins; G A Bruns; P St George-Hyslop; M L Van Keuren; D Patterson; S Pagan; D M Kurnit; R L Neve
Journal:  Science       Date:  1987-02-20       Impact factor: 47.728

View more
  48 in total

1.  Epigallocatechin-3-gallate Inhibits Cu(II)-Induced β-2-Microglobulin Amyloid Formation by Binding to the Edge of Its β-Sheets.

Authors:  Tyler M Marcinko; Thomas Drews; Tianying Liu; Richard W Vachet
Journal:  Biochemistry       Date:  2020-03-03       Impact factor: 3.162

Review 2.  The structure and phase of tau: from monomer to amyloid filament.

Authors:  Yifan Zeng; Jing Yang; Bailing Zhang; Meng Gao; Zhengding Su; Yongqi Huang
Journal:  Cell Mol Life Sci       Date:  2020-10-19       Impact factor: 9.261

3.  Lipid Membranes Influence the Ability of Small Molecules To Inhibit Huntingtin Fibrillization.

Authors:  Maryssa Beasley; Alyssa R Stonebraker; Iraj Hasan; Kathryn L Kapp; Barry J Liang; Garima Agarwal; Sharon Groover; Faezeh Sedighi; Justin Legleiter
Journal:  Biochemistry       Date:  2019-10-17       Impact factor: 3.162

Review 4.  Perspectives on the recent developments with green tea polyphenols in drug discovery.

Authors:  Feng Li; Yongli Wang; Dapeng Li; Yilun Chen; Xuguang Qiao; Rania Fardous; Ashton Lewandowski; Jinbao Liu; Tak-Hang Chan; Q Ping Dou
Journal:  Expert Opin Drug Discov       Date:  2018-04-24       Impact factor: 6.098

5.  Detection of TAR DNA-binding protein 43 (TDP-43) oligomers as initial intermediate species during aggregate formation.

Authors:  Rachel L French; Zachary R Grese; Himani Aligireddy; Dhruva D Dhavale; Ashley N Reeb; Niraja Kedia; Paul T Kotzbauer; Jan Bieschke; Yuna M Ayala
Journal:  J Biol Chem       Date:  2019-03-01       Impact factor: 5.157

Review 6.  Inhibition of protein misfolding and aggregation by natural phenolic compounds.

Authors:  Zohra Dhouafli; Karina Cuanalo-Contreras; El Akrem Hayouni; Charles E Mays; Claudio Soto; Ines Moreno-Gonzalez
Journal:  Cell Mol Life Sci       Date:  2018-07-20       Impact factor: 9.261

Review 7.  Interactions between Microtubule-Associated Protein Tau (MAPT) and Small Molecules.

Authors:  Jennifer N Rauch; Steven H Olson; Jason E Gestwicki
Journal:  Cold Spring Harb Perspect Med       Date:  2017-07-05       Impact factor: 6.915

Review 8.  Immunotherapeutic Approaches Targeting Amyloid-β, α-Synuclein, and Tau for the Treatment of Neurodegenerative Disorders.

Authors:  Elvira Valera; Brian Spencer; Eliezer Masliah
Journal:  Neurotherapeutics       Date:  2016-01       Impact factor: 7.620

Review 9.  Therapeutic approaches in Parkinson's disease and related disorders.

Authors:  Elvira Valera; Eliezer Masliah
Journal:  J Neurochem       Date:  2016-02-10       Impact factor: 5.372

10.  Stabilization of α-Synuclein Fibril Clusters Prevents Fragmentation and Reduces Seeding Activity and Toxicity.

Authors:  Huy T Lam; Michael C Graber; Katherine A Gentry; Jan Bieschke
Journal:  Biochemistry       Date:  2016-01-22       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.